Consistently, MECP2 is known to control the transcription of stress response-regulating genes [26, 27], and to tune immune function and cytokine production [28], whose alterations have been described in patients with PTSD [22, 29–33]. The gene discussed is MECP2; the disease is post-traumatic stress disorder.